VOM Intensive: Biphasic Hyaluronic Acid Dermal Filler
VOM Intensive is a cross-linked, biphasic hyaluronic acid (HA) dermal filler formulated for mid-to-deep dermis injection. Manufactured via patented R2 (Rotation & Revolution) technology, it provides high viscoelasticity for facial tissue volumization and severe wrinkle correction. The inclusion of 0.3% lidocaine hydrochloride reduces injection pain.
Core Clinical Specifications
Composition: Cross-linked HA 20 mg/mL
Lidocaine: 3 mg/mL (0.3%)
Volume: 1.0 mL × 2
Endotoxin Level: < 0.1 EU/mL
Residual BDDE: < 2 ppm
pH Level: 6.8 – 7.5
Storage: 2-25°C (Do not freeze)
Shelf Life: 24 months
Included: 27G ½” & 30G ½” UTW
VOM Product Line Matrix
Patented R2 Technology & Rheology
The R2 (Rotation and Revolution) cross-linking process blends high molecular weight HA in a centrifugal environment. This dual-action mixing maximizes the cross-linking efficiency of BDDE, resulting in a dense, uniform multiphase hydrogel matrix.
Clinical advantage: The gel maintains high cohesivity to prevent migration, while the uniform particle distribution minimizes the Tyndall effect and guarantees smooth extrusion force (average 15-20N) through a 27G.
Rheological Data:
• Viscosity (η*): 65,000 – 80,000 cP
• Phase Angle (δ): < 10° (indicates strong gel-like behavior)
• Swelling Ratio: Balanced to minimize post-injection edema
Clinical Administration Protocol
Administration must be performed strictly by licensed medical professionals trained in facial anatomy and injection techniques.
1. Preparation: Disinfect the target area with chlorhexidine or 70% isopropyl alcohol. Verify integrity and expiration date.
2. Injection Technique: Utilize linear threading, serial puncture, or fanning techniques. Aspirate prior to injection to avoid intravascular placement.
3. Dosage: Maximum recommended dose is 2.0 mL per treatment session. Inject 0.05-0.1 mL per puncture point.
4. Post-Treatment: Apply gentle massage to conform the gel to tissue contours. Apply ice packs for 10-15 minutes to reduce erythema and edema.
Medical Review & Quality Assurance
Kquality-assured (Class IV Medical Device). Manufactured in compliance with and standards.
Data sourced from manufacturer internal clinical studies demonstrating 94% patient satisfaction at 24 weeks post-injection based on the WSRS (Wrinkle Severity Rating Scale).
Medical Disclaimer & Contraindications
For licensed medical practitioners only. Do not inject intravascularly. High risk of vascular occlusion, ischemia, or necrosis if injected into blood vessels.
Contraindicated for patients with known hypersensitivity to hyaluronic acid, lidocaine, or gram-positive bacterial proteins. Clinical outcomes vary based on patient anatomy and tissue metabolism.


Reviews
There are no reviews yet.